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Conclusions: To our knowledge, this is the ﬁrst report describing the
material properties of mineralized regions of articular cartilage. The
decreased aggregate modulus in the mineralized locations as compared
to control locations diminishes the ability of articular cartilage to bear
loads and may contribute to the development of articular cartilage
degeneration. Previous work has shown that regions of mineralization
in the rat articular cartilage contain aggregates composed primarily of
b-tricalcium phosphate. The effect of variations in size and morphology of
the mineralized regions on the resulting material properties remains to
be investigated. If using a model in which mineralization of the articular
cartilage occurs naturally, care must be taken to avoid confounding
any treatment effects with the effects of the naturally occurring
mineralization.
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Purpose: AMP-activated protein kinase (AMPK) is a “super-regulator”
of energy homeostasis and cellular metabolism. AMPK increases muscle
endurance, and has been observed to exert anti-inﬂammatory effects,
mediated in part by inhibition of NF-úB activation. AMPK is constitutively
active in normal articular chondrocytes, but was recently discovered to
be decreased in human knee OA chondrocytes (Arthritis Rheum 2011,
Epub). In addition, the inﬂammatory cytokines IL-1b and TNFa reduce
AMPK activity in normal articular chondrocytes. AMPK pharmacological
activators are able to attenuate cartilage/chondrocyte pro-catabolic
responses to IL-1b and TNFa. Since biomechanical injury promotes
development and progression of OA, we tested if mechanical injury
alters chondrocyte AMPK activity, and carried out a translational study
of effects of AMPK activators on chondrocyte catabolic responses to
excessive mechanical stress.
Methods: Normal bovine articular chondrocytes embedded in alginate
in 3-D circular discs were subjected to sublethal dynamic compression
(22% maximum compression, 12% amplitude, 0.5Hz) for 16 hours in
a custom-made mechanical bioreactor, and then cultured for 0, 1, 2,
and 5 days. Non-compressed chondrocyte-alginate discs were used as
controls. Catabolic activities of chondrocytes (nitric oxide (NO) and GAG
release, MMP-3 and MMP-13 release), caspase-3 expression and AMPK
activity (phosphorylation of AMPKa) were assessed under each condition
in the presence or absence of pharmacologic AMPK activators (AICAR,
and the exquisitely selective activator A769662).
Results: Post-injury, there was signiﬁcant induction of NO release
(>10 fold, p2 fold increase, p< 0.01) and MMP-3 and MMP-13
release in mechanically injured chondrocytes, compared with controls.
This occurred as early as 1 day, progressed at 2 days and was
sustained to 5 days post-compression. Decreased phosphorylation
of AMPKa, indicative of decreased AMPK activity, was observed in
mechanically injured chondrocytes in direct correlation with increased
catabolic responses. Preservation of AMPK activity by pretreatment of
chondrocyte-alginate discs with either AICAR or A769662, before the
compression, attenuated each of the catabolic responses (NO, GAG,
MMP-3, MMP-13) to mechanical injury (P < 0.05 for each).
Conclusions: Mechanical injury to articular chondrocytes rapidly
induced loss of AMPK activity, and ushers in multiple catabolic responses.
Catabolic responses to mechanical injury were signiﬁcantly prevented
by pretreatment with AMPK activators. Targeted activation of AMPK, by
pharmacological, dietary, and other means, may have the potential to
protect articular cartilage from degradation caused by biomechanical
injury, and prevent and slow OA progression.
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LOAD-INDUCED PROGRESSIVE LESIONS ARE ASSOCIATED WITH
PROTEOGLYCAN LOSS BUT NOT WITH CELL DEATH
B. Poulet1, I.M. Khan2, C.W. Archer2, A.A. Pistillides1. 1The Royal Vet. Coll.,
London, United Kingdom; 2Cardiff Sch. of BioSci.s, Cardiff, United Kingdom
Purpose: Osteoarthritis (OA) is a disease of the joint resulting in
progressive articular cartilage (AC) degeneration, pain and movement
restriction. It is known that many individuals will acquire AC lesions,
but not all will progress to develop OA. The factors that control this
progression remain, however, unknown. We recently characterised an
adjustable murine joint loading model and demonstrated that modifying
the number of applied loading episodes could control whether the
induced lesions worsened with time or not1. This offers an opportunity
to deﬁne factors that drive progressive AC degeneration and herein
we describe histological features, including proteoglycan (PG) loss,
glycosaminoglycan (GAG) synthesis and chondrocyte cell death that may
distinguish progressive from non-progressive lesions.
Methods: Right knees of 8 week-old male CBA mice were loaded
either once and analysed 2 hours or 2 weeks thereafter (non-
progressing lesions), or loaded repetitively 3 times per week for 2 weeks
(progressing) and analysed immediately or 3 weeks after the last loading
episode (limb use was habitual in the interim)1. Coronal 6mm wax
sections, adjacent to AC lesions in the lateral femur, were stained with
Safranin O to reveal PG loss, H&E and TUNEL for cell death and labelled
using immunohistochemistry for UGDH protein expression (rate-limiting
in GAG monosaccharide synthesis).
Results: Repetitively loaded mouse knee joints, containing progressing
AC lesions, exhibit loss of Safranin O staining intensity. This was not
evident in joints loaded once only containing non-progressing AC lesions.
In contrast, UGDH protein was lost from AC chondrocytes surrounding
lesions induced by either single (non-progressing) or multiple loading
episodes (progressing). In addition, empty lacunae and decreased
cellularity was seen in H&E stained sections around the lesions in joints
loaded once and left for 2 weeks as well as in joints loaded repetitively
(non-progressive and progressive respectively). TUNEL staining showed
that cells were undergoing active cell death as soon as 2 hours after the
initial loading episode.
Conclusions: This study shows that progressive load-induced lesions are
associated with a decrease in PG content in the AC that is not only
due to decreased PG synthesis. In addition, the localised but marked
chondrocyte death evident in all loaded joints suggests that this PG
degradation is not necessarily achieved by an active contribution from
neighbouring cells. Further studies are currently being undertaken to
determine the molecular processes involved, as these may ultimately be
targeted to slow OA progression.
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ABILITY OF PEAK KNEE ADDUCTION MOMENT AND KNEE
ADDUCTION MOMENT IMPULSE TO DISTINGUISH BETWEEN CLINICAL
AND STRUCTURAL DISEASE SEVERITY
C.O. Kean, R.S. Hinman, K. Bowles, K.L. Bennell. Univ. of Melbourne,
Melbourne, Australia
Purpose: The peak knee adduction moment (KAM) during gait is a valid
proxy for medial knee joint loading and is related to progression of knee
osteoarthritis (OA). However it only measures the load at one instance
of stance. For this reason KAM impulse, which takes into account the
duration of stance, may provide more comprehensive information about
medial knee joint loading. The purpose of this study was to examine
whether peak KAM and KAM impulse during gait can distinguish
between individuals with mild and severe knee OA based on measures
of clinical and structural disease severity.
Methods: Baseline data from 169 participants (96F, 73M; 64±8yrs;
28.5±4.4m/kg2) recruited for a clinical trial evaluating lateral wedge
insoles on slowing structural OA progression were used for this study.
Participants completed radiographic and magnetic resonance imaging,
the Western Ontario and McMaster Universities Arthritis Index (WOMAC)
and a three-dimensional gait analysis. Receiver Operating Characteristic
(ROC) curve analyses were used to examine whether peak KAM and KAM
impulse could correctly classify participants based on ﬁve classiﬁcations:
Kellgren-Lawrence (KL) grading (KL grade less than or equal to 2 vs KL
grade greater than 2), absence/presence of medial bone marrow lesions
(BMLs), absence/presence of medial cartilage defects, high/low WOMAC
pain (based on a median score of 8) and less/more varus alignment
(based on a median alignment of 181°). ROC curves were created
by plotting sensitivity against 1-speciﬁcity, and area under the curve
(AUC) with 95% conﬁdence intervals (CI) were determined. Analyses of
covariance (ANCOVAs) compared peak KAM and KAM impulse between
groups while controlling for key demographic characteristics that were
statistically different between groups.
Results: When using KL grade to classify severity, the AUC for KAM
impulse (0.69, 95%CI 0.61–0.76) was signiﬁcantly greater than peak KAM
